In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed.
Current treatments increasingly fail due to multidrug-resistant pathogens. ETH researchers have now applied to patent a novel approach for developing new tuberculosis drugs.
Consumption was one of the worst known diseases of the 18th century. Thanks to medical advances, the number of deaths from this lung disease – which is today known as tuberculosis – has declined significantly. Efforts to eradicate the disease in the 1950s and 1960s resulted in a wide range of new drugs entering the market.
And yet 1.4 million people still continue to die each year from tuberculosis. Multidrug-resistant strains of the disease-causing pathogen are especially dangerous because they can no longer be treated with today’s drugs (see box). “In the past 50 years, only one new tuberculosis drug has come on to the market, and that was in 2012,” says Karl-Heinz Altmann, Professor of Pharmaceutical Biology at ETH Zurich. New active substances that are able to kill multidrug-resistant strains of the disease are therefore urgently needed. Altmann and his team have now laid the foundation for new tuberculosis drugs, and they were inspired by a bacteria-derived antibiotic called pyridomycin.
The Latest on: Tuberculosis drugs
via Google News
The Latest on: Tuberculosis drugs
- Coronavirus crisis: ICMR allows TB-testing machine to boost screening processon April 10, 2020 at 5:48 am
The Indian Council of Medical Research (ICMR) has validated the use of TrueNat, a machine that is used to detect drug-resistant Tuberculosis, for coronavirus testing in India. It was approved by the ...
- Top Medical Body ICMR Approves Use Of Diagnostic Machine Used For Drug-Resistant TB For COVID-19on April 10, 2020 at 5:36 am
As part of its efforts to ramp up the testing capacity, the Indian Council of Medical Research (ICMR) has approved the use of diagnostic machines used for testing drug-resistant tuberculosis for ...
- 100-year-old vaccine for tuberculosis could help fight coronaviruson April 10, 2020 at 5:31 am
As researchers scramble to find new drugs and vaccines for , a vaccine that is more than a century old has piqued researchers’ interests. The Bacillus Calmette-Guerin vaccine -- which was first ...
- Coronavirus Update: Can This Century-Old Tuberculosis Vaccine Help Fight COVID-19?on April 10, 2020 at 3:50 am
The old BCG vaccine can protect against more than just tuberculosis. But can it work against the coronaviruses?
- ICMR Approves Use of Diagnostic Machine Used for Drug-resistant TB for COVID-19on April 10, 2020 at 3:24 am
The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test, the apex health research body said on Friday.
- BCG: How a 100-year-old vaccine for tuberculosis could help fight Covid-19on April 10, 2020 at 2:55 am
As researchers scramble to find new drugs and vaccines for Covid-19, a vaccine that is more than a century old has piqued researchers' interests. The Bacillus Calmette-Guerin vaccine -- which was ...
- How a 100-year-old vaccine for tuberculosis could help fight the novel coronaviruson April 10, 2020 at 2:39 am
As researchers scramble to find new drugs and vaccines for Covid-19, a vaccine that is more than a century old has piqued researchers' interests.
- Tuberculosis Treatment Drugs Market to Observe 'Explosive Growth ' to Generate Massive Revenue in Coming Yearson April 8, 2020 at 3:19 pm
The MarketWatch News Department was not involved in the creation of the content. Apr 08, 2020 (HTF Market Intelligence via COMTEX) -- This intelligence report provides a comprehensive analysis of the ...
- Global Tuberculosis Drugs Market 2020 Outlook, Industry Size, Share, Growth, Geographical Segmentation, Comprehensive Analysis by 2026on April 5, 2020 at 3:20 pm
Global Tuberculosis Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 presents ...
- Germany testing tuberculosis drug as coronavirus treatmenton April 3, 2020 at 6:04 pm
A microbiologist in Germany believes that the use of an updated version of a 100-year-old Tuberculosis vaccine may work as an intermediate treatment for Covid-19. CNN's Frederik Pleitgen reports.
via Bing News